TRACEY RESPESS: Open Payments
NPI 1548474463 · CHOCOWINITY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 26 payments from 11 companies in 2025. Trend: 2023 $332 · 2024 $614 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $119 |
| Novo Nordisk Inc | 4 | $76 |
| Abbott Laboratories | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| Amgen Inc. | 3 | $49 |
| Viatris Specialty LLC | 1 | $26 |
| Astellas Pharma US Inc | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: ELIQUIS, GARDASIL 9, FREESTYLE LIBRE 3, Ozempic, AIRSUPRA, OTEZLA, Wegovy, YUPELRI.
Industry payments across NC — which companies pay providers there.
